메뉴 건너뛰기




Volumn 34, Issue 12, 2002, Pages 1660-1662

Interleukin-2, ganciclovir, and high-dose zidovudine for the treatment of AIDS-associated primary central nervous system lymphoma [3]

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; GANCICLOVIR; INTERLEUKIN 2; LOPINAVIR PLUS RITONAVIR; STAVUDINE; ZIDOVUDINE;

EID: 0037097508     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/340724     Document Type: Letter
Times cited : (17)

References (10)
  • 2
    • 0036133513 scopus 로고    scopus 로고
    • Focal neurological disease in patients with acquired immunodeficiency syndrome
    • (2002) Clin Infect Dis , vol.34 , pp. 103-115
    • Skiest, D.J.1
  • 5
    • 0033834917 scopus 로고    scopus 로고
    • Epidemiological, biological, and clinical features of HIV-related lymphomas in the era of highly active antiretroviral therapy
    • (2000) AIDS , vol.14 , pp. 1675-1688
    • Tirelli, U.1    Spina, M.2    Gaidano, G.3
  • 6
    • 0035834473 scopus 로고    scopus 로고
    • Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery
    • (2001) AIDS , vol.15 , pp. 2119-2127
    • Hoffman, C.1    Tabrizan, S.2    Wolf, E.3
  • 7
    • 0032574916 scopus 로고    scopus 로고
    • Long-term remission of AIDS-primary central nervous system lymphoma associated with highly active antiretroviral therapy
    • (1998) AIDS , vol.12 , pp. 952-954
    • McGowan, J.P.1    Shah, S.2
  • 10
    • 0028294009 scopus 로고
    • Long survival in patients with acquired immune deficiency syndrome-related primary central nervous system lymphoma
    • (1994) Cancer , vol.73 , pp. 1728-1730
    • Chamberlain, M.C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.